---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-028265"
form_type: "8-K"
ticker: "DMRA"
cik: "0001800315"
company_name: "Damora Therapeutics, Inc."
filed_at: "2023-06-15T23:59:59+00:00"
generated_at: "2026-06-14T00:27:53.160094+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Galecto stockholders elect three Class III directors and ratify EY as auditor at 2023 annual meeting

## Summary
- Elected Jayson Dallas, Amit Munshi, and Hans Schambye as Class III directors with 9.9M, 10.5M, and 10.5M votes for, respectively.
- Ratified EY Godkendt Revisionspartnerselskab as independent auditor for FY 2023 with 16.0M votes for, 52,661 against.
- Broker non-votes of 5.5M on director election; no broker non-votes on auditor ratification.
- Total shares present or represented: 16.1M out of 25.7M entitled to vote.

## SEC filing metadata
- accession: 0000950170-23-028265
- form_type: 8-K
- ticker: DMRA
- cik: 0001800315
- company_name: Damora Therapeutics, Inc.
- filed_at: 2023-06-15T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1800315/000095017023028265/0000950170-23-028265-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1800315/000095017023028265/glto-20230614.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-028265
- JSON: https://secwatch.observer/filing/0000950170-23-028265.json
- Plain text: https://secwatch.observer/filing/0000950170-23-028265.txt

## Key facts
- Shareholder Votes
  Damora Therapeutics, Inc. shareholders approved Election of Class III Directors at the 2023-06-14 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-14
  source text: (a) Election of Class III Directors. Director Nominee Votes For Votes Withheld Jayson Dallas, M.D. 9,917,146 696,399 Amit Munshi 10,526,701 86,844 Hans Schambye, M.D., Ph.D. 10,508,799 104,746 There were 5,508,817 broker non-votes regarding the election of directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1800315/000095017023028265/0000950170-23-028265-index.htm
- Shareholder Votes
  Damora Therapeutics, Inc. shareholders approved Ratification of the appointment of EY Godkendt Revisionspartnerselskab as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-06-14 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-14
  source text: (b) Ratification of the appointment of EY Godkendt Revisionspartnerselskab as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. Stockholders ratified the appointment of EY Godkendt Revisionspartnerselskab as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. The results of the voting included 16,042,725 votes for, 52,661 votes against and 26,976 votes abstained. There were no broker non-votes regarding this proposal.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1800315/000095017023028265/0000950170-23-028265-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.